TSI Pharmaceuticals

Headquartered in Pinkenba, Queensland, this Brisbane-based contract manufacturer and product developer provides end-to-end support for health and nutraceutical products. The organization operates a vertically integrated platform built around three divisions—Bio-Active Ingredients, Innovative Products, and Contract Manufacturing—facilitating rapid concept-to-market execution for brands. Our TGA-licensed facilities are engineered for high-volume production while upholding rigorous quality standards, regulatory alignment, and full process visibility.

Core capabilities cover multiple solid dosage forms and related packaging workflows. Services include:

• Tablets, capsules, effervescents, powders, and sachets
• Custom formulation and product development with stability testing and regulatory support
• Contract manufacturing with scalable batch sizes and automated order tracking
• Packaging services for primary and secondary packaging, labeling, design, and compliance-ready documentation
• FZZR Technology sachet system enabling multiple actives in one sachet while keeping others separate until use
• In-house quality systems validated for global audits and ongoing compliance

Operational scale is substantial: packaging capacity supports more than 1.8 billion tablets and over 1 billion capsules annually, with powders and effervescents offered in flexible formats. The platform emphasizes global regulatory readiness through in-country resources and audits by authorities including TGA, SFDA, FDA, EDQM, and SUKL, serving customers in 34+ markets.

In addition, a comprehensive Packing Service handles design, labeling, and automated packaging for glass or plastic bottles and jars, with steps from automated label application to batch coding, capping, oversealing, and shrink wrapping. This combination of contract manufacturing, product development, and packaging creates a streamlined path from concept to market for nutraceuticals and health supplements.